Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-03-14)Premium Content

Dendreon Corp. (DNDN)

2014-04-23@05:33:38 ET
Form 4: Update Filing for Dendreon Corp (DNDN) (VKR)

2014-04-23@05:33:28 ET
Form 4: Update Filing for Dendreon Corp (DNDN) (VKR)

2014-04-18@05:22:15 ET
Dendreon announces encouraging data from Phase II prostate cancer analysis (DTM)

2014-04-18@05:22:15 ET
Dendreon announces encouraging data from Phase II prostate cancer analysis (DTM)

2014-04-17@06:33:11 ET
Global Hormone-Sensitive Prostate Cancer Global Clinical Trials Review 2014 - Profiles of 16 Top Organisations (MTO)

2014-04-17@00:31:18 ET
Dendreon Releases Preliminary Data from Analysis of Phase II Stand Study (CLM)

2014-04-16@06:05:29 ET
Global Therapeutic Vaccines Market 2014-2018 with Agenus, Bavarian Nordic A/S, Dendreon, GSK & Novartis International Dominating (MTO)

2014-04-12@05:53:00 ET
Form 4: Update Filing for Dendreon Corp (DNDN) (VKR)

2014-04-12@05:52:49 ET
Form 4: Update Filing for Dendreon Corp (DNDN) (VKR)

2014-04-11@07:00:43 ET
Immune Responses Enhanced and Sustained When PROVENGE(R) (sipuleucel-T) is Given After Androgen Deprivation Therapy in Biochemically-Recurrent Prostate Cancer (BIZ)

2014-04-10@21:01:36 ET
Dendreon CorporationCorporate Event Announcement Notice (WSH)

2014-04-09@20:58:43 ET
Dendreon CorporationCorporate Event Announcement Notice (WSH)

2014-04-02@05:29:29 ET
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014 (MTO)

2014-04-01@05:45:46 ET
Form 4: Update Filing for Dendreon Corp (DNDN) (VKR)

2014-03-28@11:51:45 ET
The Global Vaccine Market Forecast is Expected to Grow at a CAGR of around 12% during 2012-2017 (MTO)

2014-03-24@10:46:00 ET
Pre-Market Pulse - Health Care Sector Stocks -- Research on Exelixis, StemCells, Dendreon, and Vivus (PRN)

2014-03-18@08:00:49 ET
Portola Pharmaceuticals Appoints John H. Johnson to Board of Directors (PMZ)

2014-03-06@00:25:04 ET
Dendreon Reports Intent to Make Provenge Commercially Available in Europe (CLM)